Price $355.12 |
Market Cap
94.39B
|
Sector Health Care |
Div. Growth
10.30%
|
|
P/E
17.5
|
P/B
2.0
|
P/S
0.48
|
Dividend %
1.60%
|
|
P/CF
63.7
|
P/FCF
9.8
|
Op. Cash Flow
12.45M
|
FCF
31.6
|
|
Op. Margin
4.30%
|
Net Margin
2.80%
|
ROE
11.80%
|
ROI
11.20%
|
|
ROA
3.60%
|
EPS Growth
-15.50%
|
Current Ratio
0.7
|
Debt/Equity
62.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
| Journey Medical Corp (DERM) | $4.70 | - | - | 43.3M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $108.39 | - | - | 8.13B | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $3.16 | - | - | 2.3M | Strong Buy |
| Inotiv Inc (NOTV) | $1.44 | - | - | 46.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
